These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34783492)

  • 1. Five Days of Antibiotic Therapy Is Comparable with 10 Days in Children with Community-Acquired Pneumonia.
    Barry HC
    Am Fam Physician; 2021 Nov; 104(5):Online. PubMed ID: 34783492
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
    Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
    JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
    Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
    JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia: 3 days of antibiotics for uncomplicated course.
    J Hosp Med; 2006 Nov; 1(6):387. PubMed ID: 17219539
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
    Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children.
    Ross RK; Hersh AL; Kronman MP; Newland JG; Metjian TA; Localio AR; Zaoutis TE; Gerber JS
    Clin Infect Dis; 2014 Mar; 58(6):834-8. PubMed ID: 24399088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
    Lovera D; Arbo A
    J Chemother; 2005 Jun; 17(3):283-8. PubMed ID: 16038522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
    el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
    BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
    Haider BA; Saeed MA; Bhutta ZA
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005976. PubMed ID: 18425930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to common bacterial infections: community-acquired pneumonia.
    Iroh Tam PY
    Pediatr Clin North Am; 2013 Apr; 60(2):437-53. PubMed ID: 23481110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
    Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
    Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
    Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D
    PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
    Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
    Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
    Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
    Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
    Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
    Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reducing the duration of antibiotic therapy in acute community-acquired pneumonia].
    Groupe Entretiens du Club de réflexion sur l'infection respiratoire
    Rev Pneumol Clin; 2008 Feb; 64(1):3-7. PubMed ID: 18603172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.